SCHEMBL3215950

SCHEMBL3215950

Cc1cccnc1C1CCN(S(=O)(=O)c2ccccc2Cl)CC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 6/20 0.48
OPRM1 P35372 1/20 0.48
OPRL1 P41146 1/20 0.48
POLB P06746 1/20 0.45
CHRM5 P08912 1/20 0.44
MET P08581 1/20 0.43
CHRM4 P08173 1/20 0.43
EPHX2 P34913 2/20 0.43
HDAC3 O15379 1/20 0.43
HDAC4 P56524 1/20 0.43
HDAC1 Q13547 1/20 0.43
HDAC7 Q8WUI4 1/20 0.43
HDAC2 Q92769 1/20 0.43
HDAC10 Q969S8 1/20 0.43
HDAC11 Q96DB2 1/20 0.43
HDAC8 Q9BY41 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
HDAC9 Q9UKV0 1/20 0.43
HDAC5 Q9UQL6 1/20 0.43
ALOX15 P16050 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3209708 0.86 MEN1 (0.47) OPRM1OPRL1MET
SCHEMBL3219576 0.83 TP53 (0.58) MAPK1
SCHEMBL3213867 0.82 KMT2A (0.51) FAAHPOLBHDAC3HDAC4HDAC1
SCHEMBL3219485 0.81 HSD11B1 (0.50) OPRM1OPRL1CHRM5MAPK1
SCHEMBL2962518 0.81 FAAH (0.53) FAAHCHRM4EPHX2HDAC3HDAC4
SCHEMBL3221578 0.79 TP53 (0.62)
SCHEMBL3207513 0.78 HSD11B1 (0.50) POLBCHRM5
SCHEMBL3213314 0.78 LMNA (0.60) CHRM5MAPK1
SCHEMBL3224518 0.78 HSD11B1 (0.65) CHRM4
SCHEMBL2955821 0.74 MMP2 (0.61) FAAHHDAC3HDAC4HDAC1HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100029648-A1 11-Beta HSD1 Inhibitors XIANG JASON SHAOYUN 2010-02-04 US disclosed
US-7632838-B2 11-beta HSD1 inhibitors WYETH (US) 2009-12-15 US disclosed
EP-1981848-A2 11-BETA HSD1 INHIBITORS Wyeth (US) 2008-10-22 EP disclosed
US-20070219198-A1 11-Beta HSD 1 inhibitors WYETH (US) 2007-09-20 US disclosed
WO-2007092435-A2 11-BETA HSD1 INHIBITORS WYETH (US) 2007-08-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029648-A1 11-Beta HSD1 Inhibitors HSD11B1, HSD3B1, HSD11B2 FAAH 163/4885OPRM1 3163/4885OPRL1 2846/4885
US-20070219198-A1 11-Beta HSD 1 inhibitors HSD11B1, HSD11B2, HSD3B1 FAAH 105/4885OPRM1 2457/4885OPRL1 1804/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.